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Lysis of virus-infected  cells  by human  serum  requires  both  IgG antibody  to  the 
virus and an intact  alternative  complement pathway.  It has been shown that in the 
presence of antibody, serum either immunoehemically depleted of C4 or genetically 
deficient in C2 can lyse virus-infected cells, whereas factor-B-depleted serum cannot. 
In these studies  either  anti-viral  IgG or its F(ab')2 fragment  induced lysis in serum, 
whereas its Fab' fragment did not (1, 2). These observations were made with a variety 
of RNA- and DNA-budding viruses, and a range of human sera containing antibody 
to virus, suggesting that this might be a  mechanism of wide biological applicability 
and relevance for clearing virus-infected cells. 
It  has  recently  been  shown  that  an  intact  alternative  pathway  of complement 
activation can be assembled from six isolated plasma proteins: C3, factors B  and D, 
fllH, C3b inactivator  (C3bINA), 1 and properdin  (P)  (3). Combination of the above 
six proteins  and  the  five proteins  of the  membrane-attack  pathway  of complement 
((25,  C6, C7, C8, and C9)  at  their respective physiological concentrations, led to the 
formation of a  cytolytically active alternative  pathway whose function was qualita- 
tively and quantitatively  identical to the alternative pathway in serum. The isolated 
cytolytic alternative pathway was capable of lysing rabbit erythrocytes (4) and, upon 
addition  of lysozyme, certain strains of Esherichia coli  (5)  with an efficiency virtually 
identical to C4-depleted human serum. 
The availability of the isolated cytolytic alternative  pathway allowed us to defini- 
tively  examine  the  complement-dependent  lysis  of antibody-coated  measles  virus- 
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infected  HeLa  cells.  In  this  communication  we  report  that  by  using  the  isolated 
cytolytic alternative pathway we have been able to document the absolute role of the 
alternative pathway and IgG antibody in the mediation of this lysis. This study also 
demonstrates  that  although  properdin  is not  essential for alternative-pathway acti- 
vation by these antibody-coated cells, it is absolutely required for their lysis. 
Materials  and  Methods 
Virus and Cells.  HeLa cells were acutely infected with measles virus (Edmonston strain) at 
a  multiplicity of infection  of one  plaque-forming  unit  per  cell,  and  then  maintained  in 
suspension culture in minimal essential Eagle's medium supplemented with  10% fetal bovine 
serum, glutamine, and antibiotics (MEM) for 40 h;  100% of cells then showed surface staining 
with fluorescein-conjugated measles antibody (1) and cell viability was >90%. 
Cytotoxicity Assay.  In initial studies, lysis was assessed by the eosin microcytotoxicity assay as 
in previous studies (1,2). A small-scale  SlCr-release assay was developed to facilitate quantitation 
of lysis while still enabling the use of small volumes of reagents. Infected cells were washed in 
51  6  o  MEM and labeled with  Cr (200 pCi/3  ×  10  cells in 500 pl MEM for 45 min at 37  C). 2 
×  105 cells in 100 pl MEM were then incubated with varying amounts of IgG or its fragments 
for 30 min at 4°C, washed once, and suspended at  1 ×  10  e cells/ml in serum-free MEM with 
0.01  M  Hepes and  0.1%  ovalbumin  (Ovalbumin grade V,  Sigma Chemical Co.,  St.  Louis, 
Mo.). 5-pl fractions containing 5  ×  10  a cells were dispensed in wells of a  U  microtiter plate 
(Cooke Engineering Co., Alexandria, Va.) and the complement source was added in amounts 
ranging from 0 to 30 pl diluted in Veronal-buffered saline (VBS), containing 1.2 mM MgCI2, 
0.15 mM CaCI2, and 0.1% ovalbumin (VBS  +÷ OVA). After incubation for 90 min at 37°C, 200 
pl of phosphate-buffered saline were added to each well, the plate was centrifuged at 1,000 rpm 
for 5 min and 150 btl of supernate from each well was counted. Maximum release was obtained 
with 1% Nonidet P-40 (Shell Chemical Co., New York) and spontaneous release in MEM alone 
was  10%  or  less  of the  maximum.  Specific release  was  calculated  from  the  formula:  the 
percentage of specific release  =  (sample -  spontaneous release)/(maximum  -  spontaneous 
release). 
Preparation of Immunochemically Depleted Sera.  Human  sera immunochemically depleted of 
specific complement proteins were prepared as described elsewhere (6) by adsorption with the 
IgG fraction of monospecific antiserum covalently coupled to Sepharose 4B (Pharmacia Fine 
Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.). Sera depleted of complement proteins 
but with intact C1  activity were prepared by passage through such affinity columns in VBS 
containing 1.0 M  NaCI and 2 mM EDTA. These sera depleted of alternative pathway proteins 
exhibited total hemolytic titers against antibody-coated sheep  erythrocytes of >90%  of the 
control normal serum. C4-depleted serum prepared in this manner could also be reconstituted 
with regard to control serum upon addition of physiological concentrations of purified C4. 
Purified Complement Components.  (23 (7), factor B (8), factor D  (9), C3bINA (10), fllH (10), P 
(11),  C5 (7), C6 (12),  C7  (12), C8 (13), and C9 (14) were prepared as described. Purity of the 
isolated proteins was assessed, in part, by sodium dodecyl sulfate (SDS) polyacrylamide gel 
eleetrophoresis. Representative gel patterns have been published previously (4). In this study, 
at least two different preparations of each protein were used. Proteins were radioiodinated using 
the lactoperoxidase method of David and Reisfeld (15). 
Preparation of the Isolated Cytolytic Alternative Pathway.  The mixture of purified components at 
their physiological concentrations was prepared as described (4).  Possible (23b contamination 
of C3 preparations was eliminated by incubation of C3 with appropriate amounts offllH and 
(23b inactivator just before the addition of the other eight isolated proteins. Final component 
concentrations were:  1,200 pg/ml C3, 200 pg/ml factor B, 2 pg/ml factor D, 470 pg/ml fllH, 
34 pg/ml C3bINA, 20 btg/ml P, 72 pg/ml C5, 64 #g/ml C6, 54 #g/ml C7, 54 #g/ml C8, and 58 
#g/ml (29. Before use in the cytotoxicity assays, the isolated component mixture was tested for 
its ability to lyse rabbit erythrocytes as described previously (4) and compared with C4-depleted 
serum. 
Antibody.  The IgG fraction of serum from patients with subacute sclerosing panencephalitis 
was  isolated by  anion  exchange  chromatography  and  concentrated  to  24  mg/ml.  F(ab')2 SISSONS  ET AL.  447 
TABLE  I 
Role of Alterhative Complement Pathway in IgG and Complement-dependent Lysis of Measles Virus-infected 
HeLa Cells by Serum 
Depletion experiments 
Component depleted  Percentage of lysis in 
depleted serum 
Reconstitution experi- 
ments: percentage  of 
lysis on addition of de- 
pleted component 
%  % 
None (normal serum)  95  -- 
Factor B  5  95 
Factor D  7  95 
P  20  95 
C4  95  -- 
C2  95  -- 
Human sera  containing IgG antibody to  measles  virus  were  immunochemical[y depleted  of various 
complement components by affinity chromatography (as described in Methods),  except for C2 which was 
obtained from a patient with genetic deficiency of C2. Depleted sera were reconstituted with a physiological 
concentration of the purified depleted component. Lysis was assessed by the eosin microcytotoxicity  assay 
(1). Data represent  the results of three experiments.  Spontaneous lysis of infected cells in MEM was 5 + 
10%; lysis  of uninfected HeLa cells in reagents was 5 +  5% (mean ±  2 SD). 
fragments were prepared by digestion of IgG with 3% wt/wt pepsin, and Fab' were obtained by 
reduction of F(ab')2 with dithiothreitol and alkylation with iodoaeetamide (16).  There was no 
evidence of IgG  in the  F(ab')2 or  F(ab')2 in the  Fab' preparations on overloaded  7%  SDS 
polyacrylamide gel electrophoresis under nonreducing conditions. IgG and its fragments were 
radiolabeled with 125I by the lactoperoxidase method using Enzymobeads (Bio-Rad Laborato- 
ries, Richmond, Calif.). 
Antibody-binding Assays.  Infected cells were incubated with a25I-labeled IgG, F(ab')2 or Fab' 
under the same conditions as were used to precoat cells with antibody for the cytotoxicity assay. 
Cells were then layered on 300 #1 of 20% sucrose in a  microfuge tube, pelleted in a  Beckman 
microfuge (Beckman Instruments, Inc., Fullerton, Calif.) for  1.5 min, the tip of the tube was 
cut off,  and radioactivity in pellet and supernate was determined. 
Kinetics of C3 Uptake.  2  X  107 cells in 200/11 VBS ++ OVA were incubated in 200/LI  of the 
mixture of the six isolated alternative pathway proteins containing [12SI]C3, at 37°C. Aliquots 
of 2  ×  106 cells were removed at timed points and the cells pelleted through 20% sucrose in 
VBS ++ OVA as above; [125I]C3b uptake was calculated from the number of counts in the pellet. 
[125I]C3b uptake from the same component mixture containing 0.01 M  EDTA was simultane- 
ously determined at each time point, and served as a control. 
Results 
Lysis  of  Measles  Virus-infected Cells  by  Sera  Depleted  of  Specific  Complement 
Components.  The  ability  of  serum  containing  antibodies  to  measles  virus  to  lyse 
measles  virus-infected  HeLa  cells  was  abolished  by  immunochemical  depletion  of 
individual components of the alternative complement pathway. As shown in Table I, 
immunochemical  depletion of factor  B,  factor  D, or P, significantly abrogated  lysis. 
Reconstitution  of  the  depleted  serum  with  physiologic  amounts  of  the  depleted 
component totally restored the lytic activity. In contrast, immunochemical depletion 
of C4 or genetic deficiency of C2  did not abrogate  lysis, in confirmation of previous 
results. 
Comparative studies showed that results given by the small-scale 5]Cr-release assay 
correlated well with those obtained in the eosin dye microcytotoxicity assay used  in 448  ALTERNATIVE PATHWAY LYSIS OF MEASLES-INFECTED CELLS 
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Fro.  1.  Requirements  for IgG, F(ab')2 and  Fab' for lysis of measles virus-infected ceils via the 
isolated cytolytic alternative  pathway  (ICAP). 2  ×  l0  s measles virus-infected HeLa  cells were 
preincubated  with increasing amounts of IgG (×) or its F(ab')2 (O)  and  Fab' (0)  fragments as 
described in Methods. 5 ×  l0  s cells were then incubated with 20 #1 of the ICAP and lysis assessed 
by 5]Cr release as described. Data  for lysis are plotted against the number of molecules of IgG, 
F(ab')z or Fab' binding per measles virus-infected cell, as determined in a parallel binding assay 
using 125I-labeled antibody or fragments. 
the above experiments and in previous studies (1, 2); maximum 51Cr release correlated 
with  morphological  cell  death.  Kinetic  studies  showed  that  lysis  of infected  cells 
coated with IgG began at 30 min and was maximal by 60-90 min. 
Lyric Activity of the Isolated Cytolytic Alternative Pathway.  Measles virus-infected HeLa 
cells coated with IgG (at the maximal dose used in the IgG dose-related lysis curve in 
Fig.  1)  were  incubated  in  C4-depleted  human  serum,  whole human  serum  without 
antibody,  or  the  mixture  of  11  proteins  which  constitute  the  isolated  cytolytic 
alternative  pathway.  The dose-related  lysis curves  (Fig.  2)  showed  that  the  isolated 
cytolytic alternative pathway and C4-depleted serum were functionally equivalent in 
their  capacity  to  lyse  virus-infected  cells;  50%  lysis  required  5  /~1  of the  isolated 
cytolytic alternative  pathway  or  14 #1  of C4-depleted  serum.  Lysis of infected  cells 
without antibody and of uninfected cells, incubated in the isolated cytolytic alternative 
pathway or C4-depleted serum, was not greater than  in the MEM  control.  Heating 
the isolated cytolytic alternative  pathway at  50°C  for 20 min completely abrogated 
lysis of IgG-coated cells. 
Requirements  for IgG, F(ab')z, and Fab'.  The amounts of IgG, F(ab')2, or Fab' required 
to  induce  lysis  of measles  virus-infected  cells  in  the  isolated  cytolytic  alternative 
pathway were determined.  Fig.  1 shows the dose-related  lysis produced  by preincu- 
bating the cells with  increasing quantities  of IgG, F(ab')2, or Fab'. The results  from 
the cytotoxicity assay are plotted against the number of IgG, F(ab')2, or Fab' molecules 
binding per cell, as determined  from a  binding assay using these same proteins after 
radiolabeling and performed under conditions identical to those used to precoat cells 
for the lysis assay.  Equivalent  amounts of IgG, F(ab')a, or Fab' bound per cell  for a 
given amount of protein offered (e.g., twice as many Fab' as F(ab')2 molecules bound 
for an  equal  amount  of offered  protein).  The dose-related  lysis  curves  for IgG and 
F(ab')2 are very similar, but comparable amounts of Fab' did not induce lysis. Binding 
of 4  X  107 molecules of F(ab')2 or 6.5  X  107 molecules of IgG antibody per cell was 
required  for tysis of 50%  of the  measles  virus-infected  cells by the isolated  cytolytic 
alternative pathway. In contrast, binding of >1  ×  108 molecules per cell of Fab' did SISSONS ET AL.  449 
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Fie.  2.  Dose-related lysis of measles virus-infected HeLa cells coated with IgG antibody to measles 
virus by the following sources of complement (C) whole human serum lacking antibody to measles 
([]), human serum immunochemically depleted of C4 (O), and the ICAP (O). Lysis  was assessed by 
5]Cr release as in Methods. Each point represents the mean of duplicate assays +  1 SE. There was 
no lysis of uninfected HeLa cells or infected cells without antibody. 
not  induce  any  lysis  by the  isolated  cytolytic alternative  pathway,  despite  the  fact 
that this was equivalent to the amount of the divalent F(ab')2 inducing maximal lysis. 
Requirement for P for Cell Lysis.  P  has been previously shown to play a  nonessential 
but  enhancing  role  in  the  alternative-pathway-mediated  deposition  of C3b  onto 
activating particles  (3), and for the lysis of rabbit erythrocytes (4)  and certain gram- 
negative bacteria (5). In contrast to the aforementioned activators, the lysis of measles 
virus-infected  cells  is  dependent  upon  antibody  and  the  target  is  a  nucleated  cell 
presumably capable of effecting membrane repair. We therefore examined the role of 
P  in the lysis of these cells. As shown in Fig. 3, deletion of P from the isolated cytolytic 
alternative  pathway totally abrogated  the lysis of IgG-coated virus-infected  cells.  In 
parallel experiments,  the same reaction mixtures containing or lacking P  were tested 
for their  ability  to  lyse rabbit  erythrocytes.  Results  obtained  were  similar  to those 
previously reported  (4)  which showed that deletion of P  only reduced lysis of rabbit 
erythrocytes by a  factor of 2.6. 
Enhancement of Pathway  Activation by  P.  To  determine  the  role  P  plays  in  the 
activation  of the  alternative  pathway  by these  cells,  the  kinetics  of C3b  deposition 
onto  antibody-coated  measles  virus-infected  cells  were  studied  using  the  isolated 
alternative  pathway  either  containing or lacking  P.  As shown  in  Fig.  4,  P  was not 
absolutely  required  for  C3b  deposition  onto  the  cell  surface  but  did  enhance  the 
kinetics of pathway activation.  In the presence of P, C3b was rapidly deposited onto 
the IgG-coated measles virus-infected cells during the  1st  10-20 min of the reaction. 
At  60  min,  15  ×  105  C3b  molecules  were  bound  per  cell.  Deletion  of P  from the 
reaction mixture significantly decreased the rate of C3b deposition but had less effect 
on the number of C3b molecules ultimately bound per cell.  After incubation  of the 
cells  for 60  min  with  the  isolated  protein  mixture  lacking  P,  C3b  deposition  was 
approaching that which was seen in the presence of P. 
The deposition of C3b onto antibody-coated virus-infected cells from the isolated 
alternative  pathway  containing  0.01  M  EDTA  has  been  subtracted  at  each  time 450  ALTERNATIVE PATHWAY  LYSIS OF MEASLES-INFECTED  CELLS 
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Flo.  3.  Requirement  for P for lysis  of IgG-coated measles virus-infected HeLa cells by the ICAP. 
Lysis of 5 ×  l0  s IgG-coated infected cells by increasing doses of the ICAP (O) and the ICAP with 
P omitted (0). 
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F[c. 4  Effect  of P on the kinetics of [12SI]C3 uptake from the isolated alternative  pathway (IAP) 
by IgG coated measles virus-infected HeLa cells. [12BI]C3 uptake, measured as described in Methods, 
is shown from the I.AP containing P (O) and with  P omitted (O). [[25I]C3 uptake  fiom the IAP 
containing 0.01 M EDTA has been subtracted  at each time point. 
point; this deposition in the presence of EDTA averaged 3  ×  105 C3b molecules per 
cell and showed no increase with time. 
Discussion 
This study makes the following points.  First, measles virus-infected cells are lysed 
by IgG antibody to measles virus, or its F(ab')2 fragment, and the components of the 
isolated  cytolytic alternative  pathway,  a  system  composed  solely of the  11  highly 
purified  proteins  of  the  alternative  pathway  of activation  and  membrane  attack 
pathway of complement. IgG and F(ab')2 induce equivalent dose-related lysis by the 
isolated  cytolytic alternative  complement  pathway,  whereas  comparable  or  larger 
doses of Fab' are  ineffective.  Second,  this lysis of measles  virus-infected HeLa  cells 
exhibits an absolute requirement for P. Third, P  is not essential for C3b uptake onto 
the measles virus-infected cell in the presence of antibody but  does enhance the rate 
at which deposition occurs. SISSONS ET AL.  451 
These observations provide conclusive evidence for the role of IgG antibody and 
the alternative complement pathway in the lysis of measles virus-infected cells.  They 
thus confirm earlier findings from this laboratory that lysis of virus-infected cells by 
whole serum is dependent on the presence of IgG and an intact alternative pathway 
(1,  2).  Furthermore, the use of the  11  highly purified cytolytic alternative pathway 
components rules out  the  participation  of any other serum  factors in  this  process. 
These results also demonstrate that the proteins of the isolated cytolytic alternative 
pathway are sufficient for activation and cell lysis in a system where lysis is dependent 
on IgG, and are functionally equivalent in this respect to the pathway in whole serum. 
The fact that  both IgG and  F(ab')2  fragments of measles antibody-induced lysis 
extends previous findings (2) by showing that IgG and F(ab')2 are equally effective on 
a  molecular basis  in inducing lysis over a  range of doses.  Moreover, an equivalent 
amount  of Fab' bound to the infected cell was totally ineffective in inducing lysis. 
This clear requirement for divalent IgG may indicate that the role of IgG is to group 
or patch viral antigen on the surface of infected cells or alternatively, that a site other 
than the combining site, present on F(ab')2 but lost on reduction to Fab', is required 
for IgG to induce lysis. 
We found an absolute requirement for P  for the lysis of virus-infected HeLa cells. 
The fact that deletion of factor B or D abrogates lysis (Table I) would be expected as 
both are required, with C3, for generation of the alternative pathway C3 convertase 
C3bB.  P,  however, is a  regulatory protein, whose demonstrated function is that  of 
delaying the rapid intrinsic decay of C3bB.  Moreover, P  has been shown not to be 
essential for the lysis of rabbit erythrocytes (4) or E.  coli  (5) by the isolated cytolytic 
alternative pathway.  The contrasting requirement shown  here may reflect the fact 
that lysis of nucleated cells, which have the capacity for membrane repair, probably 
requires extensive C3 deposition and generation of C5b-C9 complexes on the plasma 
membrane, both of these events would be enhanced by P. The accelerated C3 uptake 
shown here in the presence of P is consistent with its established function of stabilizing 
C3bB. 
Other  workers  have  also  reported  that  measles  virus-infected cells  are  lysed  by 
antibody  and  the  alternative  pathway  in  serum,  although  they  sometimes  used 
heterologous sera as a source of complement (17,  18). Hicks et al.  (17)  reported that 
both classical and alternative pathways combined were considerably more effective 
than either alone. In contrast, as shown here, the isolated cytolytic alternative pathway 
is of comparable efficiency to whole serum in dose-related lysis of virus-infected cells; 
this  suggests  a  minor  or  negligible  contribution  of the  classical  pathway  to  lysis, 
despite the fact that the IgG bound to the infected cell is capable of causing C3 uptake 
by activation of the classical pathway. It should be emphasized that by employing a 
cell line of human origin and human antibody and complement sources, our experi- 
ments avoid problems inherent in the use of heterologous sera. 
The mechanism by which IgG induces lysis via the alternative pathway is unknown. 
The production of lysis by the  isolated  cytolytic alternative pathway conclusively 
rules  out  any  possibility  that  C1  could  be  activating  the  alternative  pathway,  as 
described for the lysis of sheep erythrocytes heavily sensitized with IgG antibody by 
C4-deficient guinea pig serum  (19).  This mechanism was viewed as unlikely on the 
basis of the previously described lack of requirement for calcium ions for lysis of virus- 
infected cells, which can be mediated by magnesium EGTA serum (1, 2). 452  ALTERNATIVE PATHWAY LYSIS OF MEASLES-INFECTED CELLS 
Current evidence indicates that  solid-phase initiation of the alternative pathway 
depends on distinctive surface properties of the known particulate activators, such 
that  C3b  deposited  on  them  from  the  fluid  phase  is  protected  from  its  serum 
inactivators (20, 21, 3). Thus, it has been shown that access of/~lH to C3b deposited 
on activating particles is restricted (22, 23), the C3b is protected from the concerted 
inactivating  effects of/~IH  and  C3bINA,  and  the  C3  convertase, C3bB,  can  be 
generated  with  subsequent  amplification  of 123  turnover  and  surface  deposition, 
binding of P, and cleavage of C5 (3, 24). There is no information available to suggest 
how IgG might play a  role in such a  scheme of activation. Our own studies, to be 
presented elsewhere, indicate that measles virus-infected cells can activate the alter- 
native pathway in the absence of IgG and that, although IgG is essential for lysis, it 
does not itself initiate activation. 
Thus,  the  dominant  role of the  alternative pathway in  the  antibody-dependent 
and-complement-dependent lysis of virus-infected cells is now amply established; the 
precise  role  of IgG  or  its  F(ab')2  fragment  in  inducing  such  lysis  remains  to  be 
uncovered. 
Summary 
The dependence of antibody-and-complement-mediated lysis ofvirus-infected cells 
on the alternative pathway was examined utilizing the isolated cytolytic alternative 
pathway--a system consisting of the six purified proteins of the alternative pathway 
of activation (C3, factors B and D,/31H, C3b inactivator and properdin), and the five 
proteins of the membrane attack pathway (125-9) of complement. HeLa cells acutely 
infected with  measles  virus were lysed by anti-viral  IgG and  the isolated cytolytic 
alternative pathway with an efficiency comparable to whole human serum. IgG and 
its F(ab')2 fragment were equally effective in inducing lysis by the isolated cytolytic 
alternative pathway, binding of ---5 ×  l0  7 molecules per cell being required for 50% 
lysis;  in contrast, no lysis occurred when equivalent or greater amounts of Fab' were 
bound to the virus-infected cell. Properdin was required for lysis. No lysis occurred if 
properdin was deleted from the isolated cytolytic alternative pathway, and lysis was 
diminished by 80% in properdin-depleted serum. Uptake of [x25I]C3b from the isolated 
alternative  pathway  onto  measles  virus-infected  cells  occurred  in  the  absence  of 
properdin, but was accelerated in the presence of properdin. The  11 proteins of the 
isolated cytolytic alternative pathway are  thus sufficient for lysis of measles  virus- 
infected cells bearing anti-viral IgG or F(ab')z without any other serum protein. 
The authors acknowledge the technical assistance of M. Brothers and L. Wood, and the aid of 
M.  Pangburn,  E.  Podack,  A.  Esser, and  G.  Biesecker  of the  Department  of Molecular 
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